Skip to content
Sign in
StableHealthReported 2026-11-17 00:45

Hagens Berman files securities class action against CVRx following DOJ CID and revenue guidance cut

A federal class action lawsuit was filed against CVRx, Inc. after the company disclosed a U.S. Department of Justice Civil Investigative Demand, a significant revenue guidance cut, sales force deterioration, and a collapse in Medicare Advantage approval rates. The complaint alleges CVRx misled investors about its commercial sales force and reimbursement rates.

In depthRead the in-depth story

Why it matters. CVRx investors with substantial losses are directly affected; the litigation stems from disclosed regulatory and commercial setbacks that triggered a 60% stock price drop and the abrupt termination of the Chief Revenue Officer.

01

Who and what it touches

Barostimpart ofAnti-Kickback Statuteregulatory exposureFalse Claims Actregulatory exposureCVRx

Into CVRx

From CVRx

Each line is a relation with evidence behind it, drawn in the direction it points. A line shows that two things are connected, not how far this change reaches.

02

Evidence

  • PPR Newswire news releasesCompany2026-11-17 00:45
    SAN FRANCISCO, Nov. 16, 2026 /PRNewswire/ -- Hagens Berman, a national shareholder rights litigation firm, alerts investors in **CVRx, Inc. (NASDAQ: CVRX)** to a class action lawsuit filed in federal court. The filing follows disclosures of a U.S. Department of Justice Civil Inv…
    View source